The journal offers optional funded open access. Click here for more information.

JCP is a proud member of the Committee on Publication Ethics (COPE).

For more than 50 years, clinical pharmacologists, clinical and pharmaceutical researchers, drug development specialists, physicians, nurses, and other medical professionals have relied on The Journal of Clinical Pharmacology (JCP) for original research, special reviews, commentaries, and case reports on all phases of drug development from absorption, disposition, metabolism, excretion interactions, and preferred uses through post-marketing evaluations.

JCP features studies such as:

• Mechanism of action
• Dosage levels
• Absorption, metabolism, and excretion
• Safety and efficacy
• Drug-drug interactions
• Effectiveness and impact on quality of life
• Special populations, including women, children and the elderly
• Cost-effectiveness
• New clinical trial designs
• Clinical Pharmacokinetics and Pharmacodynamics
• Clinical Trials and Human Pharmacology
• Experimental Pharmacology in In Vitro and In Vivo Studies
• Applications of Modeling and Simulation
• Pharmacoepidemiology / Pharmacogenomics
• Pharmacoeconomics / Disease Management
• Translational Medicine / Biomarkers / Imaging
• Decision-making in Research and Development

The journal provides physicians and pharmacologists with well-written, original research on a broad range of topics related to:

• Analgesia
• Behavioral Pharmacology
• Biochemical Pharmacology
• Drug Development
• Education
• Cardiovascular Pharmacology
• Chemotherapy
• Immunopharmacology
• Molecular Pharmacology
• Neuropharmacology
• Pediatric Pharmacology
• Pharmacoeconomics
• Pharmacoepidemiology
• Pharmacodynamics
• Pharmacokinetics
• Toxicology

JCP was selected as one of the "Journals of the Century" (Journals of the Century, The Haworth Information Press, 2002).

This journal is a member of the Committee on Publication Ethics (COPE).